Atreon Orthopedics received FDA 510(k) clearance to market the Rotium™ Bioresorbable Wick for use in rotator cuff repair.
Rotium is a synthetic bioresorbable scaffold. Inserted between a repaired tendon and bone, it acts as a facilitator to enhance tendon healing. Animal study of acute and chronic models has demonstrated an improvement in tendon strength from repairs using Rotium vs. without the device.
Atreon Orthopedics is a subsidiary company of ParaGen Technologies, which is itself a joint venture between Nanofiber Solutions, the technology developer, and Ikove Venture Partners, which provides full operational support, market strategy and access to funding via a global network of investors.
Atreon Orthopedics received FDA 510(k) clearance to market the Rotium™ Bioresorbable Wick for use in rotator cuff repair.
Rotium is a synthetic bioresorbable scaffold. Inserted between a repaired tendon and bone, it acts as a facilitator to enhance tendon healing. Animal study of acute and chronic models has demonstrated an improvement in...
Atreon Orthopedics received FDA 510(k) clearance to market the Rotium™ Bioresorbable Wick for use in rotator cuff repair.
Rotium is a synthetic bioresorbable scaffold. Inserted between a repaired tendon and bone, it acts as a facilitator to enhance tendon healing. Animal study of acute and chronic models has demonstrated an improvement in tendon strength from repairs using Rotium vs. without the device.
Atreon Orthopedics is a subsidiary company of ParaGen Technologies, which is itself a joint venture between Nanofiber Solutions, the technology developer, and Ikove Venture Partners, which provides full operational support, market strategy and access to funding via a global network of investors.
Copy to clipboard 
